News article

Innovative Medicines Initiative 2 (IMI 2) Launches New Calls Worth €434 Million

19/07/2018

IMI2 Calls 15 and 16 now open to applications.

The Innovative Medicines Initiative (IMI) is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). Through the IMI2 programme, it has a €3.3 billion budget for the period 2014-2020 to develop next generation vaccines, medicines and treatments, such as new antibiotics.

Register to read full article